A Galacto-Oligosaccharides Preparation Derived From Lactulose Protects Against Colorectal Cancer Development in an Animal Model

Javier Fernández,F. J. Moreno,Agustín Olano,Alfonso Clemente,Claudio J. Villar,Felipe Lombó
DOI: https://doi.org/10.3389/fmicb.2018.02004
IF: 5.2
2018-08-31
Frontiers in Microbiology
Abstract:Colorectal cancer (CRC) is one of the most common neoplasias worldwide, and its incidence is increasing. Consumption of prebiotics is a useful strategy in order to prevent this important disease. These nutraceutical compounds might exert protective biological functions as antitumors. In order to test the chemopreventive effect of GOS-Lu (galacto-oligosaccharides derived from lactulose) prebiotic preparation against this cancer, an animal model (<i>Rattus norvegicus</i> F344) was used. In this model, two doses of azoxymethane (10 mg/kg) and two treatments with dextran sodium sulfate (DSS) were administered to the animals. Animals were fed for 20 weeks, and either control drinking water or drinking water containing 10% (w/w) GOS-Lu prebiotic preparation was provided to them. Animals were sacrificed after those 20 weeks, and their digestive tract tissues were analyzed. The results revealed a statistically significant reduction in the number of colon tumors in the GOS-Lu cohort with respect to control animals. Metagenomics sequencing was used for studying colon microbiota populations, revealing significant reductions in populations of pro-inflammatory bacteria families and species, and significant increases in interesting beneficial populations, such as <i>Bifidobacterium</i>. Therefore, oral administration of the prebiotic GOS-Lu preparation may be an effective strategy for preventing CRC.
microbiology
What problem does this paper attempt to address?